Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;63(1):3-11.
doi: 10.1097/GRF.0000000000000507.

Updates in Cervical Cancer Treatment

Affiliations
Review

Updates in Cervical Cancer Treatment

Emily K Hill. Clin Obstet Gynecol. 2020 Mar.

Abstract

Although rates of cervical cancer in the United States have been declining due to vaccination and screening efforts, it remains the fourth most common cancer in women worldwide and is still far from being eradicated, even in developed nations. This review discusses recent developments in cervical cancer treatment and reviews the literature supporting recent practice changes encompassing staging, surgical management, radiation, chemotherapy, targeted agents including immunotherapy, and imaging.

PubMed Disclaimer

References

    1. Bhatla N, Aoki D, Sharma DN, et al. FIGO Cancer Report 2018: cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143(suppl 2):22–36.
    1. Matuso K, Machida H, Mandelbaum RS, et al. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019;152:87–93.
    1. Berek JS, Matuso K, Grubbs BH, et al. Multidisciplinary perspectives on newly revise 2018 FIGO staging of cancer of the cerxi uteri. J Gynecol Oncol. 2019;30:e40.
    1. Lanciano R, Calkins A, Bundy BN, et al. Randomized comparision of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervical cancer: a gynecologic oncology group study. J Clin Oncol. 2005;23:8289–8295.
    1. Havrilesky LJ, Kulasingam SL, Matchar DB, et al. FDG-PET for management of cercial and ovarian cancer. Gynecol Oncol. 2005;97:183–191.

MeSH terms

Substances